cyclosarin

cyclosarin
Name	cyclosarin
IUPAC name	methylphosphonofluoridic acid 2-cyclohexyl ethyl ester
Other names	GF
CAS number	1566-95-8
Formula	C8H15FO2P
Molar mass	188.15 g·mol−1

cyclosarin

Introduction

Cyclosarin is an organophosphorus nerve agent developed during the World War II and Cold War eras, associated with binary chemical weapons research and stockpiling by states such as the Soviet Union and alleged programs in Iraq and other countries. It is classified alongside agents like sarin, tabun, soman, VX and covered by the Chemical Weapons Convention and scrutiny from the Organisation for the Prohibition of Chemical Weapons. Responses to cyclosarin have involved institutions including the Centers for Disease Control and Prevention, the World Health Organization, and national ministries of defense and health.

Chemical structure and properties

The molecule is an organophosphorus ester with a phosphorus–fluorine bond and a cyclohexyl-containing alkoxy chain, analogous in framework to sarin and soman but with increased lipophilicity similar to VX. Its physical properties—density, vapor pressure, and viscosity—affect dispersal and persistence; these properties were evaluated by laboratories in the United States, United Kingdom, and Soviet Union and reported in classified and declassified studies held by agencies like the Central Intelligence Agency and the Defense Intelligence Agency. Cyclosarin’s boiling point and low vapor pressure render it more persistent than highly volatile agents such as sarin, influencing tactical considerations exemplified in analyses by the RAND Corporation and military chemical warfare manuals from the United States Army and NATO.

Synthesis and manufacture

Synthesis pathways historically trace to organophosphorus chemistry developed by industrial and military research groups in Germany and the United Kingdom during the 20th century, with later process developments in the Soviet Union and facilities linked to the Iraqi chemical weapons program. Production routes use precursors controlled under schedules maintained by the Organisation for the Prohibition of Chemical Weapons and involve reagents similar to those in syntheses of sarin and soman. Chemical engineering adjustments for large-scale manufacture were documented in reports by the Royal Society and technical papers referenced by the National Research Council and subject to interdiction efforts by export-control regimes such as the Australia Group.

Mechanism of action

Cyclosarin acts by inhibiting acetylcholinesterase at synaptic junctions in the peripheral and central nervous systems, producing effects documented in comparative neuropharmacology literature alongside sarin and soman. The molecular interaction with the active site of acetylcholinesterase has been modeled in structural studies by teams at institutions like the Max Planck Institute for Biophysical Chemistry, Massachusetts Institute of Technology, and Imperial College London, drawing on crystallography methods developed at the European Molecular Biology Laboratory. These studies informed antidotal strategies used by emergency services coordinated with agencies such as the Federal Emergency Management Agency and protocols promulgated by the European Centre for Disease Prevention and Control.

Toxicology and clinical effects

Acute exposure produces muscarinic, nicotinic, and central nervous system signs: bronchorrhea, bronchospasm, miosis, muscle fasciculations, seizure, and respiratory failure—clinical syndromes described in case series from incidents analyzed by the World Health Organization, Centers for Disease Control and Prevention, and military medical corps like the United States Army Medical Research Institute of Chemical Defense. Comparative toxicology with agents such as VX, soman, and sarin appears in toxicology texts from publishers associated with Johns Hopkins University Press and reviews by committees of the National Academies of Sciences, Engineering, and Medicine. Long-term neurological sequelae and epidemiological follow-up have been topics for research groups at the University of Oxford, Harvard Medical School, and Karolinska Institutet.

Historical use and incidents

Documented military production and stockpiling occurred in the Soviet Union with alleged battlefield or strategic reserves referenced in intelligence reports involving the Gulf War era and declassified materials from the Central Intelligence Agency and United Nations inspections. Notable incidents and allegations prompted investigations by the Organisation for the Prohibition of Chemical Weapons and reporting by media outlets such as the New York Times, The Guardian, and BBC News. Historical analyses situate cyclosarin within broader chemical weapons programs reviewed by historians at institutions like the Wilson Center, Chatham House, and the International Committee of the Red Cross.

Regulation and control

Cyclosarin and its precursors are listed under schedules of the Chemical Weapons Convention enforced by the Organisation for the Prohibition of Chemical Weapons, with export controls coordinated by the Australia Group and national authorities including the United States Department of State and the European Union Directorate-General for Trade. Disarmament and verification measures have involved multinational missions such as United Nations inspection teams and compliance assessments by panels convened under the Conference on Disarmament and reports to the United Nations Security Council.

Detection, decontamination, and medical treatment

Detection technologies employ mass spectrometry, gas chromatography, and biosensors developed by laboratories at Sandia National Laboratories, Lawrence Livermore National Laboratory, and academic groups at the University of California, Berkeley and ETH Zurich, integrating guidance from the Centers for Disease Control and Prevention and European Defence Agency. Decontamination protocols use oxidizers, adsorbents, and hydrolysis procedures delineated in standards from the National Institute of Standards and Technology and manuals from the United States Army Chemical Corps. Medical treatment emphasizes prompt administration of atropine, oxime reactivators like pralidoxime, and anticonvulsants as outlined by the World Health Organization, Red Cross, and military medical research centers including the USAMRICD (United States Army Medical Research Institute of Chemical Defense).

Category:Chemical weapons